Dr Elisabeth Lambert joined the Baker IDI Heart & Diabetes Institute, Human Neurotransmitters Laboratory, Melbourne Australia in 1999. She received her Ph.D. in 1996 from the University of Paris Sud. Dr Lambert’s research interest focuses on exploring the pathophysiological mechanisms leading to abnormal sympathetic nervous function as well as its impact on the cardiovascular system and subsequent target-organ damage in conditions associated with elevated cardiovascular risk. Dr Lambert is an expert in clinical microneurography. Her work has contributed to the understanding of abnormalities of sympathetic function and mechanism of cardiac risk in hypertension, anxiety disorders and orthostatic intolerance. Her most recent work focuses on investigating the impact of sympathetic dysfunction in obesity and metabolic disorders and examining the effects of various treatments (diet, exercise, bariatric surgery, sympatholytic & insulin sensitiser agents) on sympathetic function end organ damage in obese patients.